Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Sales | 3,293 | 2,557 | 3,419 | -8,145 | 13,852 |
| Cost of Goods | 1,979 | 1,586 | 1,680 | -8,053 | 11,443 |
| Gross Profit | 1,314 | 971 | 1,740 | -93 | 2,409 |
| Operating Expenses | 3,723 | 3,343 | 4,661 | 20,195 | 4,055 |
| Operating Income | -1,430 | -1,787 | -2,242 | -20,340 | -1,203 |
| Interest Expense | 10 | 124 | 167 | -214 | 513 |
| Other Income | -45 | -2,735 | -1,528 | -2,513 | -2,028 |
| Pre-tax Income | -1,485 | -4,645 | -3,937 | -22,639 | -3,744 |
| Net Income Continuous | -1,485 | -4,645 | -3,937 | -22,617 | -3,744 |
| Minority Interests | 12 | -24 | -1 | -189 | 66 |
| Net Income | $-1,497 | $-4,621 | $-3,935 | $-22,427 | $-3,810 |
| EPS Basic Total Ops | -0.10 | -0.59 | -1.16 | -7.58 | -1.30 |
| EPS Basic Continuous Ops | -0.10 | -0.59 | -1.16 | -7.72 | -1.26 |
| EPS Diluted Total Ops | -0.10 | -0.59 | -1.16 | -7.58 | -1.30 |
| EPS Diluted Continuous Ops | -0.10 | -0.59 | -1.16 | -7.72 | -1.26 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.30 | -0.80 | N/A | N/A |
| EBITDA(a) | $-695 | $1,506 | $-165 | $-17,351 | $1,813 |